Soteriadou K, Papavassiliou P, Voyiatzaki C, Boelaert J
Laboratory of Biochemistry, Hellenic Pasteur Institute, Athens, Greece.
J Antimicrob Chemother. 1995 Jan;35(1):23-9. doi: 10.1093/jac/35.1.23.
The development of vaccines and drugs to control leishmaniasis is urgently needed. The presence of a leishmania transferrin receptor on the parasite suggests that an adequate supply of iron is needed for the life cycle of leishmania. We have investigated the effect of iron deprivation on the growth of leishmania promastigotes in vitro using an iron chelation approach. All chelators tested reduced the rate of promastigote multiplication in a dose-dependent fashion, whereas referrated ones did not. The hydroxypyridin-4-one chelators CP94 and L1 were found to be more efficient than desferrioxamine. We suggest that iron depletion may be an effective mechanism against leishmania infection.
迫切需要开发控制利什曼病的疫苗和药物。寄生虫上存在利什曼原虫转铁蛋白受体,这表明利什曼原虫的生命周期需要充足的铁供应。我们使用铁螯合方法研究了缺铁对体外利什曼原虫前鞭毛体生长的影响。所有测试的螯合剂均以剂量依赖的方式降低了前鞭毛体的增殖速率,而参比螯合剂则没有。发现羟基吡啶-4-酮螯合剂CP94和L1比去铁胺更有效。我们认为缺铁可能是对抗利什曼原虫感染的有效机制。